Dr.Reddys Laboratories reported 23.8B in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 428.7B 424.18B
Bharat Petroleum BPCL:IN 6.28B 2.96B
Cipla CIPLA:IN 9.56B 633.3M
Dr.Reddys Laboratories DRRD:IN 23.8B 38M
Reliance Infra RELI:IN 60.03B 7.25B
UPL UPLL:IN 12.77B 590M